Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene

被引:60
作者
Bot, A [1 ]
Antohi, S [1 ]
Bot, S [1 ]
GarciaSastre, A [1 ]
Bona, C [1 ]
机构
[1] MT SINAI SCH MED, DEPT MICROBIOL, NEW YORK, NY 10029 USA
关键词
DNA vaccination; neonatal immunization; T(h)1; T(h)2;
D O I
10.1093/intimm/9.11.1641
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neonates and infants display an intrinsic disability to mount protective immune responses to influenza viruses or conventional influenza vaccines, We investigated the ability of naked DNA to prime protective immune responses by inoculating newborn and adult mice with a plasmid (pHA) expressing hemagglutinin (HA) from the neurovirulent strain A/WSN/33 of influenza virus, Continuous exposure to small doses of antigen subsequent to neonatal DNA immunization led to effective priming of specific B and T-h cells, rather than tolerance induction. The pHA immunization of adult mice primed a strongly biased T(h)1 response, whereas in neonates it induced a mixed T(h)1/T(h)2 response, In contrast to the effect of live-virus immunization, DNA immunization of neonates was followed by enhanced cytotoxic T lymphocyte responses subsequent to challenge with A/WSN/33 influenza virus, Mice immunized as neonates or adults with pHA plasmid exhibited significant increases in survival and decreases in virus lung titers following lethal challenge with the A/WSN/33 virus or the A/PR8/34 drift variant. Our results demonstrate that DNA vaccination is an efficient and safe means to generate broad humoral and cellular immune responses to influenza viruses, during the earliest stages of postnatal life.
引用
收藏
页码:1641 / 1650
页数:10
相关论文
共 45 条
[1]  
ADKINS B, 1993, J IMMUNOL, V151, P6617
[2]  
[Anonymous], [No title captured]
[3]  
BILLINGHAM R, 1956, P ROY SOC LONDON, V239, P44
[4]  
BONA C, 1978, J IMMUNOL, V120, P1436
[5]  
BOOT A, 1996, VIRAL IMMUNOL, V9, P207
[6]   Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice [J].
Bot, A ;
Reichlin, A ;
Isobe, H ;
Bot, S ;
Schulman, J ;
Yokoyama, WM ;
Bona, CA .
JOURNAL OF VIROLOGY, 1996, 70 (08) :5668-5672
[7]   ANTIGEN PRESENTATION PATHWAYS TO CLASS-I AND CLASS-II MHC-RESTRICTED LYMPHOCYTES-T [J].
BRACIALE, TJ ;
MORRISON, LA ;
SWEETSER, MT ;
SAMBROOK, J ;
GETHING, MJ ;
BRACIALE, VL .
IMMUNOLOGICAL REVIEWS, 1987, 98 :95-114
[8]  
CHANG TL, 1991, J IMMUNOL, V147, P750
[9]   VIRALLY INDUCED MODULATION OF MURINE IGG ANTIBODY SUBCLASSES [J].
COUTELIER, JP ;
VANDERLOGT, JTM ;
HEESSEN, FWA ;
VINK, A ;
VANSNICK, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) :2373-2378
[10]   PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS [J].
DONNELLY, JJ ;
FRIEDMAN, A ;
MARTINEZ, D ;
MONTGOMERY, DL ;
SHIVER, JW ;
MOTZEL, SL ;
ULMER, JB ;
LIU, MA .
NATURE MEDICINE, 1995, 1 (06) :583-587